Scienture(NASDAQ) SCNX

Current Price$0.37

Market Cap$15.89M

Since IPO (2024)-97%

5 Year-99%

1 Year-82%

1 Month+0%

Scienture last closing stock price
Metric	Price	Date
Last close	USD 0.37	2026-07-24

Scienture stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-10.8%	USD 0.41	2026-07-17
1 month	+0.27%	USD 0.37	2026-06-24
3 month	-9.97%	USD 0.41	2026-04-24
Year to date	-27.59%	USD 0.51	2025-12-31
1 year	-81.81%	USD 2.03	2025-07-24
3 year	-92.67%	USD 5.04	2023-07-25
5 year	-99.28%	USD 51.21	2021-07-23
Since inception	-96.71%	USD 11.89	2024-07-29

Scienture Financials at a Glance

Market Cap

$15.89M

Revenue (TTM)

$477.68K

Net Income (TTM)

-$41.85M

EPS (TTM)

-$1.81

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$0.37

Volume

5,000

Open

$0.39

Price

$0.37

Volume

5,000

Open

$0.39

Previous Close

$0.37

Daily Range

$0.37 - $0.39

52-Week Range

$0.24 - $2.60

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$0.37

Volume

5,000

Open

$0.39

Previous Close

$0.37

Daily Range

$0.37 - $0.39

52-Week Range

$0.24 - $2.60

Estimated Earnings Date

Aug 17, 2026

SCNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scienture

Scienture Holdings, Inc. is a multifaceted company with a strong emphasis on innovation and diverse technological solutions. It targets multiple sectors with its proprietary technologies, reinforced by a solid intellectual property portfolio. The company embraces a customer-centric approach, tailoring its offerings to meet the specific needs of its clientele.

Products and Services

Innovative technologies spanning various industries.

Bespoke solutions tailored to specific client needs.

Diverse revenue streams from multiple sector applications.

What Makes Scienture Holdings, Inc. Special

Scienture Holdings, Inc. stands out due to its commitment to innovation and customer service. By focusing on individualized client solutions, the company creates significant barriers to entry for competitors. Its diversified approach helps maintain market stability and adaptability.

Five Things You Need to Know

Robust competitive advantages driven by a commitment to innovation.

A diverse portfolio of cutting-edge technologies supported by a strong intellectual property library.

Customer-centric model offering bespoke solutions, enhancing client relationships and market position.

Leadership with strategic growth capabilities and a focus on operational excellence.

Growth strategy includes strategic partnerships and acquisitions for market expansion.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

CEO

Shankar Hariharan, PhD; Narasimhan Mani, PhD, MBA

Website

www.scienture.com

Headquarters

Commack, NY 33634, US

SCNX Financials

Key Financial Metrics (TTM)

Gross Margin

-20.69%

Operating Margin

-3387.86%

Net Income Margin

-8761.28%

Return on Equity

-0.25%

Return on Capital

-23.16%

Return on Assets

-0.05%

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.89M

Shares Outstanding

40.63M

Volume

5.00K

Avg. Volume

1.54M

Financials (TTM)

Gross Profit

-$98.81K

Operating Income

-$16.18M

EBITDA

-$39.45M

Operating Cash Flow

-$13.34M

Capital Expenditure

-$3.00

Free Cash Flow

-$13.34M

Cash & ST Invst.

$3.54B

Total Debt

$10.00M

Scienture Performance Analysis

Scienture annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 10,250,168	3.6%
2023	2023-12-31	USD 1,363,830	-86.7%
2024	2024-12-31	USD 136,643	-90.0%
2025	2025-12-31	USD 431,609	215.9%

Scienture sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-100.0%
Q3	2025-09-30	N/A
Q4	2025-12-31	-128.6%
Q1	2026-03-31	133.4%

Scienture annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -6.15	-37.3%
2023	2023-12-31	USD -23.08	275.5%
2024	2024-12-31	USD -5.49	-76.2%
2025	2025-12-31	USD -2.70	-50.7%

Scienture sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-44.0%
Q3	2025-09-30	60.0%
Q4	2025-12-31	-794.7%
Q1	2026-03-31	95.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$56.33K

+449.1%

Gross Profit

-$414.16K

-61639.8%

Gross Margin

-7.35%

N/A

Market Cap

$15.89M

N/A

Market Cap/Employee

$1.77M

N/A

Employees

N/A

Net Income

-$3.40M

-11.0%

EBITDA

-$2.90M

-21.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.54B

+172747.8%

Total Debt

$10.00M

+162.4%

Accounts Receivable

$722.55K

-86.5%

Inventory

$210.93M

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$10.01M

+288.0%

Return on Assets

-0.05%

N/A

Return on Invested Capital

-0.02%

N/A

Free Cash Flow

-$2.92M

+1.3%

Operating Cash Flow

-$2.92M

+1.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$13.85-22.28%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$3.83+0.52%

BFRGBullfrog AI Holdings, Inc. Common Stock

BFRGBullfrog AI Holdings, Inc. Common Stock$0.59-2.58%

CINGCingulate Inc.

CINGCingulate Inc.$4.64-4.13%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.54-0.04%

TRAWTraws Pharma, Inc.

TRAWTraws Pharma, Inc.$0.49-6.13%

IMNNImunon, Inc.

IMNNImunon, Inc.$1.51-9.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

STAKStak

STAKStak$9.27+6.02%

Questions About SCNX

What is the current price of Scienture?

Scienture is trading at $0.37 per share.

What is the 52-week range for Scienture?

Over the past 52 weeks, Scienture has traded between $0.24 and $2.60.

How much debt does Scienture have?

As of the most recent reporting period, Scienture reported total debt of $10.00K.

How much cash does Scienture have on hand?

Scienture reported $3.54M in cash and cash equivalents in its most recent financial results.

What is Scienture’s dividend yield?

Scienture does not currently have a dividend yield.

Scienture(NASDAQ) SCNX

Scienture Financials at a Glance

SCNX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Scienture

Products and Services

What Makes Scienture Holdings, Inc. Special

Five Things You Need to Know

SCNX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Scienture Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SCNX

What is the current price of Scienture?

What is the 52-week range for Scienture?

How much debt does Scienture have?

How much cash does Scienture have on hand?

What is Scienture’s dividend yield?

Premium Investing Services